Production of kappa-caseino-glycomacropeptide
US5216129A · kind A · utility
6Cited by
4References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 1991 |
| Grant date | Jun 1, 1993 |
| Priority date | — |
| Expiry date | Mar 21, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23J1/202
- WIPO fieldFood chemistry
- WIPO sectorChemistry
Abstract
Kappa-caseino-glycomacropeptide (CGMP) is industrially produced from a whey product concentrated in proteins partly freed from lactose by selective precipitation of the residual whey proteins with ethanol from the supernatant collected after separation of the flocculate obtained by heat treatment in acidic medium.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.